Novo Nordisk Slowdown Weighs On Denmark's Economic Outlook

Weaker prospects for pharmaceutical giant Novo Nordisk A/S (NYSE:NVS) have prompted Denmark's economic ministry to cut its 2025 GDP forecast, now expecting just 1.4% growth, down 1.5 percentage points from May's projection.

Growth is seen rebounding to 2.1% in 2026, up 0.7 points. Employment is still rising and inflation is projected to stay below 2%. The ministry said U.S. tariff hikes will further weigh on exports and global activity, while an EU-U.S. trade framework reduces uncertainty around sales ...